[PHAT] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -5.56%
YoY- 27.51%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 7,324 1,912 682 0 0 0 0 -
PBT -91,446 -82,852 -79,570 -43,243 -40,965 -37,814 -55,047 40.30%
Tax 0 171 -16,738 7,266 9,618 -146 8,405 -
NP -91,446 -82,852 -79,570 -43,243 -40,965 -37,668 -63,452 27.61%
Tax Rate - - - - - - - -
Total Cost 98,770 84,764 80,252 43,243 40,965 37,668 63,452 34.34%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -1,248.58 -4,333.26 -11,667.16 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.56 -1.42 -1.39 -0.76 -0.84 -0.89 -1.54 0.86%
EPS Diluted -1.56 -1.42 -1.39 -0.76 -0.84 -0.89 -1.54 0.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.